Evidence map›Paper›PMID 38058155›Full record

ArticleJournal of dental research2024

Novel Ameloblastin Variants, Contrasting Amelogenesis Imperfecta Phenotypes.

U Hany, C M Watson, L Liu, G Nikolopoulos, C E L Smith, J A Poulter, C J Brown, A Patel, H D Rodd, R Balmer and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of dental research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Functions of secretory calcium-binding phosphoproteins in dental mineralization.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Ameloblastin and its multifunctionality in amelogenesis: A review.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

U HanyLeeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.ORCID 0000-0002-4486-1625
C M WatsonLeeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.ORCID 0000-0003-2371-1844
L LiuLeeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.
G NikolopoulosLeeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.
C E L SmithLeeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.
J A PoulterLeeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.
C J BrownBirmingham Dental Hospital, Mill Pool Way, Edgbaston, Birmingham, UK.
A PatelLCRN West Midlands Core Team, NIHR Clinical Research Network (CRN), Birmingham Research Park (West Wing), Edgbaston, Birmingham, UK.
H D RoddAcademic Unit of Oral Health Dentistry and Society, School of Clinical Dentistry, University of Sheffield, Sheffield, S Yorks, UK.
R BalmerSchool of Dentistry, Clarendon Way, University of Leeds, Leeds, UK.
A HarfoushSchool of Dentistry, Clarendon Way, University of Leeds, Leeds, UK.
M Al-JawadSchool of Dentistry, Clarendon Way, University of Leeds, Leeds, UK.
C F InglehearnLeeds Institute of Medical Research, University of Leeds, St. James's University Hospital, Leeds, UK.ORCID 0000-0002-5143-2562
A J MighellSchool of Dentistry, Clarendon Way, University of Leeds, Leeds, UK.
University of Leeds · GBBirmingham Dental Hospital · GBBirmingham Research Park · GBUniversity of Sheffield · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Amelogenesis imperfecta (AI) comprises a group of rare, inherited disorders with abnormal enamel formation. Ameloblastin (AMBN), the second most abundant enamel matrix protein (EMP), plays a critical role in amelogenesis. Pathogenic biallelic loss-of-function

Indexed as

Amelogenesis ImperfectaDental Enamel ProteinsAmelogenesisAnimalsHumansPedigreePhenotypeAMBN protein, humanDental Enamel ProteinsAMBNamelogenesisdental enamelhypoplastic AIfounder effectX-ray microtomography

Identifiers

PMID38058155
PMCPMC10734210
OpenAlexW4389444583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.